Linked by Thom Holwerda on Mon 8th Oct 2012 09:24 UTC
Legal The failing US patent system is getting ever more mainstream - The New York Times is running a long and details piece on the failings of the system, especially in relation to the technology industry most of us hold so dearly. Most of the stuff in there isn't new to us - but there's two things in the article I want to highlight.
Thread beginning with comment 538060
To view parent comment, click here.
To read all comments associated with this story, please click here.
RE[5]: My two cents
by smashIt on Wed 10th Oct 2012 07:25 UTC in reply to "RE[4]: My two cents"
smashIt
Member since:
2005-07-06

For example, medicins take a lot of investment, but they are very cheap to reverse-engieer.


not if you take into account that the pharma-industrie spends only a fraction of their income on research, and that more than 2/3 of all developed drugs are never put on the market

Reply Parent Score: 3

RE[6]: My two cents
by jared_wilkes on Wed 10th Oct 2012 16:11 in reply to "RE[5]: My two cents"
jared_wilkes Member since:
2011-04-25

The fact that 2/3s of the developed drugs don't make it to market is exactly the point.

Reply Parent Score: 2